Pain Perception of People Who Are Unable to Have Headache

Pain Perception, Headache Provocation and Multiomics of People Who Are Unable to Have Headache

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04217616

Enrollment

100

Registered

2020-01-03

Start date

2019-10-01

Completion date

2020-03-12

Last updated

2021-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Healthy, Muscle Tenderness, Pain, Head

Keywords

Headache, Healthy, Muscle Tenderness, quantitative sensory testing, cold pain threshold, heat pain threshold, Total Tenderness Score, Cold Pressor Test, Headache Resistant

Brief summary

Headaches are extremely common illnesses with a combined lifetime prevalence of 90-99% in Europe. Despite this high prevalence, there are persons who have never, in their whole life, encountered a headache. The aim of the study is to identify factors that protect against headache by studying pain perception, muscle tenderness and pain tolerance in people who never have had a headache (headache resistant) versus non-resistant controls. The investigators hope to contribute with novelty to the current understanding of headache pathophysiology and development of more efficient treatment of headache. The investigator examining: Quantitative sensory testing (cold pain threshold and heat pain threshold), Muscle tenderness (total tenderness score) and cold pressor test (time in the water and pain rating). All tests are performed the same day, by one investigator who are blinded to the grouping of the participants.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

MALE

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Headache resistant and non-resistant male participants from the Danish Blood Donor Study. * Weight: 45 kg to 95 kg

Exclusion criteria

* Daily consumption of any medication. * Consumption of any medication less than 12 hours prior to the study day. * Headache on the study day or 48 hours prior to the study day. * Amnestic or clinical signs of hypertension (systolic blood pressure \>150 mmHg and/or diastolic blood pressure \>100 mmHg) or hypotension (systolic blood pressure \<90 mmHg and/or diastolic blood pressure \<50 mmHg). * Any severe cardiovascular disease, including cerebrovascular illness. * Amnestic or clinical signs of current mental illness. * Amnestic or clinical signs of current substance or drug abuse. * Amnestic or clinical signs of any illness the responsible doctor considers relevant for participation in the study.

Design outcomes

Primary

Measure	Time frame	Description
Quantitative Sensory Test: Cold Pain Threshold	3 hours	Difference in Cold Pain Threshold (celcius) between cases and controls.
Quantitative Sensory Test: Heat Pain Threshold	3 hours.	Difference in Heat Pain Threshold (celcius) between cases and controls.
Pericranial Muscle Tenderness: Total Tenderness Scores	3 hours	Difference in Total Tenderness Score between cases and controls. 8 pericranial muscles are palpated by the investigator and the tenderness is rated by the participant on a scale of 0-3 where 0 is no tenderness and 3 is severe tenderness.

Secondary

Measure	Time frame	Description
Cold Pressor Test: Pain Tolerance	3 hours	Difference in Cold Pressor Test Pain Tolerance (seconds) between cases and controls
Cold Pressor Test: Pain Rating	3 hours	Difference in Cold Pressor Test Pain Rating by Verbal Rating Scale (VRS) between cases and controls. The pain is rated by the participant on the Verbal Rating Scale from 0 - 10 where 0 is no pain and 10 is the most severe pain imaginable.

Countries

Denmark

Outcome results